ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Japanese pharmaceuticals team up on dementia treatment

Government to help seek breakthrough in drug delivery to brain

Japan's pharmaceutical heavyweights Takeda, Shionogi and others will team up to tackle dementia.

OSAKA -- Takeda Pharmaceutical and Shionogi & Co. are joining forces with three other Japanese drug companies to develop treatment techniques to combat dementia and similar neurological diseases.

The group is looking to establish in about two years basic technology needed to deliver medicines that remedy such disorders. Right now, no treatment is on the market worldwide that can effectively treat dementia. The same mechanism that helps to prevent viruses and bacteria from entering the brain impedes the delivery of drug compounds.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more